Saturday 17 October 2026
Export DGX’s income statement to Excel — free account
Quest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
235.00
4.15
−1.74%
Follow DGX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 14.03% | 13.95% | 14.10% | 13.64% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
8 | 8 | 7 | 8 | |
| 6.43% | 6.28% | 6.10% | 5.97% | ||
ROIC |
7.94% | 7.78% | 7.81% | 7.63% | |
Return on Tangible Assets |
32.31% | 39.57% | 42.90% | 39.87% | |
Average Days of Receivables |
52.60 | 51.36 | 46.57 | 48.98 | |
Free Cash Flow per Share |
12.15 | 12.05 | 12.24 | 12.44 | |
Free Cash Flow |
1,349.00 | 1,326.00 | 1,359.00 | 1,393.00 | |
Capital Expenditures |
(554.00) | (524.00) | (527.00) | (492.00) | |
| Other line items | |||||
Cash ROIC |
9.58% | 9.67% | 10.22% | 10.39% | |
Accounts Receivable Turnover |
7.49 | 7.54 | 8.14 | 7.66 | |
Accounts Payable Turnover |
5.25 | 5.45 | 4.92 | 5.23 | |
Inventory Turnover |
36.82 | 36.40 | 39.10 | 39.12 | |
Average Days of Payables |
75.44 | 72.67 | 79.24 | 73.48 | |
Days of Inventory on Hand |
11.00 | 10.90 | 9.36 | 9.38 | |
Tax Rate |
(0.23) | (0.24) | (0.24) | (0.23) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
17.63% | 17.69% | 17.83% | 17.78% | |
Share Based Compensation of Revenue |
0.76% | 0.76% | 0.80% | 0.83% | |
Interest Coverage |
6.37 | 6.19 | 5.89 | 5.78 | |
Operating CF/Net income |
1.80 | 1.81 | 1.91 | 1.96 | |
Depreciation/Fixed assets |
0.26 | 0.26 | 0.26 | 0.26 | |
Capex/Depreciation |
(0.96) | (0.91) | (0.92) | (0.88) | |
Revenue per Share |
104.14 | 102.53 | 99.41 | 96.88 | |
Operating CF per Share |
17.14 | 16.82 | 16.99 | 16.83 | |
Capex per Share |
(4.99) | (4.76) | (4.75) | (4.39) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 |
Columns are period end dates